Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:15 PM
Ignite Modification Date:
2025-12-24 @ 9:15 PM
NCT ID:
NCT01748604
Eligibility Criteria:
Inclusion Criteria:
* primary or secondary lymphedema,
* lymphedema stages II or III
* affecting unilateral upper or lower limb
* Excess volume (EV) \> 10%
Exclusion Criteria:
* malignancy or active neoplasm disease or lack of information about it.
* active lymphangitis
* known contraindications for Decongestive Lymphatic Therapy (DLT): renal insufficiency, uncontrolled hypertension, cardiac disease and venous thrombosis.
* a course of DLT during last year.
* anything that could alter the patient's capability to consent truly to participate in this study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01748604
Study Brief:
Protocol Section:
NCT01748604